Chemical Compound
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
CAS Registry Number
25614-03-3
Primary record
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
- 库存
- 9,588 克
- 纯度
- 98.3 %
- CAS
- 25614-03-3
化合物标识与属性
- CAS
- 25614-03-3
- PubChem CID
- 31101
- SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
- Canonical SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
名称与同义词
- bromocriptine
- Bromocryptine
- Bromocriptin
- Bromoergocryptine
- Bromergocryptine
- Bromoergocriptine
- Bromocriptina
- Bromocriptinum
- Parlodel
- Ergoset
- Bromocryptin
- Bagren
- 2-Bromo-alpha-ergocryptine
- Pravidel
- 2-Bromoergocryptine
- 2-Bromo-alpha-ergokryptin
- ergolactin
- 2-Bromo-alpha-ergokryptine
- Bromokryptine
- Ergocryptine, 2-bromo-
- Bromergon
- Apo-Bromocriptine
- Parlodel Snaptabs
- 2-Bromoergokryptine
- Alti-Bromocriptine
- 25614-03-3
- (+)-Bromocriptine
- Bromocriptinum [INN-Latin]
- Bromocriptina [INN-Spanish]
- Bromocriptine [BAN]
- 2-bromoergocriptine
- Parlodel (TN)
- 2 Bromoergocryptine
- 2 Bromoergokryptine
- BROMOCRITINE
- BROMOCRIPTINE MESYLATE
- Bromocriptine mesilate
- Bromocryptine mesylate
- Bromocriptine (mesylate)
- Bromocriptine methanesulfonate
- CB-154
- C32H40BrN5O5
- RefChem:56423
- Bromocriptine (USAN/INN)
- Bromocriptine+ (GTP+)
- Bromocriptine+ (GTP-)
- AC1L1KXS
- Prestwick0_000121
- Prestwick1_000121
- Prestwick2_000121
- 3A64E3G5ZO
- CCRIS 3244
- UNII-3A64E3G5ZO
- BROMOCRIPTINE [MI]
- Bromocriptine [USAN:BAN:INN]
- DTXSID1022687
- SANDOZ 15-754
- 2 Bromo alpha ergocryptine
- 2 Bromo alpha ergokryptine
- Biomol-NT_000005
- CHEMBL493
- D06YFA
- GTPL35
- BROMOCRIPTINE [INN]
- CHEBI:3181
- DTXCID602687
- BROMOCRIPTINE [USAN]
- Lopac0_000171
- SCHEMBL25297
- Bromocriptine [USAN:INN:BAN]
- BROMOCRIPTINE [VANDF]
- 2-Bromo-.alpha.-ergocryptine
- BIDD:GT0464
- EINECS 247-128-5
- SPBio_002101
- BROMOCRIPTINE [WHO-DD]
- OZVBMTJYIDMWIL-AYFBDAFISA-N
- BPBio1_001131
- Ergocryptine, 2-bromo-(8CI)
- 2-Bromoergocryptine Methanesulfonate
- SCHEMBL29364057
- BDBM81993
- G02CB01
- N04BC01
- (+)-Bromocriptine methanesulfonate
- CB154
- C32-H40-Br-N5-O5
- AC1Q2716
- CID31101
- Tox21_110907
- CB 154
- EBC-27415
- NSC169774
- PDSP2_001500
- ZINC53683151
- AKOS015961273
- CCG-204266
- DB01200
- SDCCGSBI-0050159.P003
- NCGC00024584-03
- NCGC00024584-04
- NCGC00024584-05
- NCGC00024584-07
- NCGC00024584-09
- NCGC00024584-17
- NCGC00024584-28
- AC-13601
- AC-37665
- BC206491
- DA-61890
- J16.988I
- LS-64540
- NCI60_001365
- CAS-25614-03-3
- CS-0012283
- FT-0623234
- FT-0623235
- NS00001292
- C06856
- D03165
- 13177-EP2272832A1
- 13177-EP2275420A1
- 13177-EP2277876A1
- 13177-EP2280008A2
- 13177-EP2287165A2
- 13177-EP2287166A2
- 13177-EP2292614A1
- 13177-EP2292620A2
- 13177-EP2295412A1
- 13177-EP2295413A1
- 13177-EP2295439A1
- 13177-EP2298731A1
- 13177-EP2298738A1
- 13177-EP2298779A1
- 13177-EP2311808A1
- 13177-EP2311818A1
- 13177-EP2311829A1
- 13177-EP2311837A1
- 13177-EP2316470A2
- 13177-EP2316834A1
- 88085-EP2298415A1
- 88085-EP2298742A1
- 88085-EP2305648A1
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
- EN300-19768234
- Q413581
- SR-01000075356
- SR-01000075356-5
- (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
- (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
- 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
- BRD-K14496212-001-01-1
- BRD-K14496212-066-02-2
- BRD-K14496212-066-04-8
- 22260-51-1
- (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
- (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-
- (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
- (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
- (5'-a2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3'
- 2-Bromo-12'-hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
- SAN 15-754; Sandoz 15-754; -Bromocryptine; -Bromoergocryptine; -Ergolactin
- (4R,7R)-10-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.0^(2,6))dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-10-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
- (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (5'-alpha)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
- (5alpha,5'beta)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
- (6aR,9R)-5-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
- 08Y
- 2-Bromo-12 -hydroxy-2 -(1-methylethyl)-5 alpha-(2-methylpropyl)ergotaman-3 ,6 ,18-trione
- 247-128-5
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1- methylethyl)-5'-(2-methylpropyl)-, (5'?)-
- Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)-
- N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide